NEW YORK (GenomeWeb) – Veracyte said today that Medicare contractor Palmetto GBA has confirmed its local coverage determination for the Percepta Bronchial Genomic Classifier, a molecular test that identifies and screens patients with lung nodules who are at low risk of cancer following an inconclusive bronchoscopy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.